1887

Microbiology Society logo

Volume 156, Issue 2

Different effects of transcriptional regulators MarA, SoxS and Rob on susceptibility of to cationic antimicrobial peptides (CAMPs): Rob-dependent CAMP induction of the operon Free

Abstract

Cationic antimicrobial peptides (CAMPs), a component of the mammalian immune system, protect the host from bacterial infections. The roles of the transcriptional regulators MarA, SoxS and Rob in susceptibility to these peptides were examined. Overexpression of , either in an antibiotic-resistant mutant or from a plasmid, decreased bacterial susceptibility to CAMPs. Overexpression of the gene from a plasmid, which decreased susceptibility to antibiotics, unexpectedly caused no decrease in CAMP susceptibility; instead it produced increased susceptibility to different CAMPs. Deletion or overexpression of had little effect on CAMP susceptibility. The operon was upregulated when was incubated in sublethal amounts of CAMPs polymyxin B, LL-37 or human -defensin-1; however, this upregulation required Rob. Deletion of increased bacterial susceptibility to polymyxin B, LL-37 and human -defensin-1 peptides. Deletion of yielded an even greater increase in susceptibility to these peptides and also led to increased susceptibility to human -defensin-2. Inhibition of cellular proton-motive force increased peptide susceptibility for wild-type and deletion strains; however, it decreased susceptibility of mutants. These findings demonstrate that CAMPs are both inducers of -mediated drug resistance through interaction with Rob and also substrates for efflux in . The three related transcriptional regulators show different effects on bacterial cell susceptibility to CAMPs.

  • Received:
  • Accepted:
  • Revised:
  • Published Online:
Keyword(s): CAMP, cationic antimicrobial peptide , CCCP, carbonyl cyanide 3-chlorophenylhydrazone , PMF, proton-motive force and RND, resistance-nodulation-division
SGM
Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.033415-0
2010-02-01
2024-04-20
Loading full text...

Full text loading...

/deliver/fulltext/micro/156/2/570.html?itemId=/content/journal/micro/10.1099/mic.0.033415-0&mimeType=html&fmt=ahah

References

  1. Akiba M., Lin J., Barton Y. W., Zhang Q. 2006; Interaction of CmeABC and CmeDEF in conferring antimicrobial resistance and maintaining cell viability in Campylobacter jejuni. J Antimicrob Chemother 57:52–60
     [Google Scholar]
  2. Alekshun M. N., Levy S. B. 1999; The mar regulon: multiple resistance to antibiotics and other toxic chemicals. Trends Microbiol 7:410–413
     [Google Scholar]
  3. Amabile-Cuevas C. F., Demple B. 1991; Molecular characterization of the soxRS genes of Escherichia coli: two genes control a superoxide stress regulon. Nucleic Acids Res 19:4479–4484
     [Google Scholar]
  4. Baba T., Ara T., Hasegawa M., Takai Y., Okumura Y., Baba M., Datsenko K. A., Tomita M., Wanner B. L., Mori H. 2006; Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol 2: 2006.0008
     [Google Scholar]
  5. Barbosa T. M., Levy S. B. 2000; Differential expression of over 60 chromosomal genes in Escherichia coli by constitutive expression of MarA. J Bacteriol 182:3467–3474
     [Google Scholar]
  6. Bengoechea J. A., Skurnik M. 2000; Temperature-regulated efflux pump/potassium antiporter system mediates resistance to cationic antimicrobial peptides in Yersinia. Mol Microbiol 37:67–80
     [Google Scholar]
  7. Bina J. E., Alm R. A., Uria-Nickelsen M., Thomas S. R., Trust T. J., Hancock R. E. 2000; Helicobacter pylori uptake and efflux: basis for intrinsic susceptibility to antibiotics in vitro. Antimicrob Agents Chemother 44:248–254
     [Google Scholar]
  8. Brissette C. A., Lukehart S. A. 2007; Mechanisms of decreased susceptibility to beta-defensins by Treponema denticola. Infect Immun 75:2307–2315
     [Google Scholar]
  9. Casaz P., Garrity-Ryan L. K., McKenney D., Jackson C., Levy S. B., Tanaka S. K., Alekshun M. N. 2006; MarA, SoxS and Rob function as virulence factors in an Escherichia coli murine model of ascending pyelonephritis. Microbiology 152:3643–3650
     [Google Scholar]
  10. Chromek M., Slamova Z., Bergman P., Kovacs L., Podracka L., Ehren I., Hokfelt T., Gudmundsson G. H., Gallo R. L. other authors 2006; The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med 12:636–641
     [Google Scholar]
  11. Cohen S. P., Hachler H., Levy S. B. 1993a; Genetic and functional analysis of the multiple antibiotic resistance ( mar) locus in Escherichia coli. J Bacteriol 175:1484–1492
     [Google Scholar]
  12. Cohen S. P., Levy S. B., Foulds J., Rosner J. L. 1993b; Salicylate induction of antibiotic resistance in Escherichia coli: activation of the mar operon and a mar-independent pathway. J Bacteriol 175:7856–7862
     [Google Scholar]
  13. D'Amato R. F., Thornsberry C., Baker C. N., Kirven L. A. 1975; Effect of calcium and magnesium ions on the susceptibility of Pseudomonas species to tetracycline, gentamicin polymyxin B, and carbenicillin. Antimicrob Agents Chemother 7:596–600
     [Google Scholar]
  14. Datsenko K. A., Wanner B. L. 2000; One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97:6640–6645
     [Google Scholar]
  15. Dorschner R. A., Lopez-Garcia B., Peschel A., Kraus D., Morikawa K., Nizet V., Gallo R. L. 2006; The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides. FASEB J 20:35–42
     [Google Scholar]
  16. Eswarappa S. M., Panguluri K. K., Hensel M., Chakravortty D. 2008; The yejABEF operon of Salmonella confers resistance to antimicrobial peptides and contributes to its virulence. Microbiology 154:666–678
     [Google Scholar]
  17. Ganz T. 2003; Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 3:710–720
     [Google Scholar]
  18. George A. M., Levy S. B. 1983; Amplifiable resistance to tetracycline, chloramphenicol, and other antibiotics in Escherichia coli: involvement of a non-plasmid-determined efflux of tetracycline. J Bacteriol 155:531–540
     [Google Scholar]
  19. Greenberg J. T., Monach P., Chou J. H., Josephy P. D., Demple B. 1990; Positive control of a global antioxidant defense regulon activated by superoxide-generating agents in Escherichia coli. Proc Natl Acad Sci U S A 87:6181–6185
     [Google Scholar]
  20. Greenberg J. T., Chou J. H., Monach P. A., Demple B. 1991; Activation of oxidative stress genes by mutations at the soxQ/cfxB/marA locus of Escherichia coli. J Bacteriol 173:4433–4439
     [Google Scholar]
  21. Gudmundsson G. H., Agerberth B., Odeberg J., Bergman T., Olsson B., Salcedo R. 1996; The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur J Biochem 238:325–332
     [Google Scholar]
  22. Guo L., Lim K. B., Poduje C. M., Daniel M., Gunn J. S., Hackett M., Miller S. I. 1998; Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell 95:189–198
     [Google Scholar]
  23. Hagman K. E., Shafer W. M. 1995; Transcriptional control of the mtr efflux system of Neisseria gonorrhoeae. J Bacteriol 177:4162–4165
     [Google Scholar]
  24. Hancock R. E. 2001; Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect Dis 1:156–164
     [Google Scholar]
  25. Jair K. W., Yu X., Skarstad K., Thony B., Fujita N., Ishihama A., Wolf R. E. Jr 1996; Transcriptional activation of promoters of the superoxide and multiple antibiotic resistance regulons by Rob, a binding protein of the Escherichia coli origin of chromosomal replication. J Bacteriol 178:2507–2513
     [Google Scholar]
  26. Jenssen H., Hamill P., Hancock R. E. 2006; Peptide antimicrobial agents. Clin Microbiol Rev 19:491–511
     [Google Scholar]
  27. Koronakis V., Eswaran J., Hughes C. 2004; Structure and function of TolC: the bacterial exit duct for proteins and drugs. Annu Rev Biochem 73:467–489
     [Google Scholar]
  28. Li J., Nation R. L., Turnidge J. D., Milne R. W., Coulthard K., Rayner C. R., Paterson D. L. 2006; Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis 6:589–601
     [Google Scholar]
  29. Ma D., Alberti M., Lynch C., Nikaido H., Hearst J. E. 1996; The local repressor AcrR plays a modulating role in the regulation of acrAB genes of Escherichia coli by global stress signals. Mol Microbiol 19:101–112
     [Google Scholar]
  30. Maneewannakul K., Levy S. B. 1996; Identification for mar mutants among quinolone-resistant clinical isolates of Escherichia coli. Antimicrob Agents Chemother 40:1695–1698
     [Google Scholar]
  31. Martin R. G., Nyantakyi P. S., Rosner J. L. 1995; Regulation of the multiple antibiotic resistance ( mar) regulon by marORA sequences in Escherichia coli. J Bacteriol 177:4176–4178
     [Google Scholar]
  32. Masuda N., Sakagawa E., Ohya S., Gotoh N., Tsujimoto H., Nishino T. 2000; Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa. Antimicrob Agents Chemother 44:3322–3327
     [Google Scholar]
  33. Miller J. H. 1972 Experiments in Molecular Genetics Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
  34. Miller P. F., Gambino L. F., Sulavik M. C., Gracheck S. J. 1994; Genetic relationship between soxRS and mar loci in promoting multiple antibiotic resistance in Escherichia coli. Antimicrob Agents Chemother 38:1773–1779
     [Google Scholar]
  35. Nicoloff H., Perreten V., McMurry L. M., Levy S. B. 2006; Role for tandem duplication and Lon protease in AcrAB-TolC-dependent multiple antibiotic resistance (Mar) in an Escherichia coli mutant without mutations in marRAB or acrRAB. J Bacteriol 188:4413–4423
     [Google Scholar]
  36. Nikaido H., Zgurskaya H. I. 2001; AcrAB and related multidrug efflux pumps of Escherichia coli. J Mol Microbiol Biotechnol 3:215–218
     [Google Scholar]
  37. Oethinger M., Podglajen I., Kern W. V., Levy S. B. 1998; Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli. Antimicrob Agents Chemother 42:2089–2094
     [Google Scholar]
  38. Oethinger M., Kern W. V., Jellen-Ritter A. S., McMurry L. M., Levy S. B. 2000; Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump. Antimicrob Agents Chemother 44:10–13
     [Google Scholar]
  39. Oh J. T., Cajal Y., Skowronska E. M., Belkin S., Chen J., Van Dyk T. K., Sasser M., Jain M. K. 2000; Cationic peptide antimicrobials induce selective transcription of micF and osmY in Escherichia coli. Biochim Biophys Acta 146343–54
     [Google Scholar]
  40. Okusu H., Ma D., Nikaido H. 1996; AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants. J Bacteriol 178:306–308
     [Google Scholar]
  41. Oren Z., Lerman J. C., Gudmundsson G. H., Agerberth B., Shai Y. 1999; Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. Biochem J 341:501–513
     [Google Scholar]
  42. Piddock L. J. 2006; Multidrug-resistance efflux pumps – not just for resistance. Nat Rev Microbiol 4:629–636
     [Google Scholar]
  43. Pomposiello P. J., Bennik M. H., Demple B. 2001; Genome-wide transcriptional profiling of the Escherichia coli responses to superoxide stress and sodium salicylate. J Bacteriol 183:3890–3902
     [Google Scholar]
  44. Rieg S., Huth A., Kalbacher H., Kern W. V. 2009; Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps. Int J Antimicrob Agents 33:174–176
     [Google Scholar]
  45. Rosenberg E. Y., Bertenthal D., Nilles M. L., Bertrand K. P., Nikaido H. 2003; Bile salts and fatty acids induce the expression of Escherichia coli AcrAB multidrug efflux pump through their interaction with Rob regulatory protein. Mol Microbiol 48:1609–1619
     [Google Scholar]
  46. Salyers A. A., Gupta A., Wang Y. 2004; Human intestinal bacteria as reservoirs for antibiotic resistance genes. Trends Microbiol 12:412–416
     [Google Scholar]
  47. Shafer W. M., Qu X., Waring A. J., Lehrer R. I. 1998; Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. Proc Natl Acad Sci U S A 95:1829–1833
     [Google Scholar]
  48. Tzeng Y. L., Ambrose K. D., Zughaier S., Zhou X., Miller Y. K., Shafer W. M., Stephens D. S. 2005; Cationic antimicrobial peptide resistance in Neisseria meningitidis. J Bacteriol 187:5387–5396
     [Google Scholar]
  49. Wandersman C., Delepelaire P. 1990; TolC, an Escherichia coli outer membrane protein required for hemolysin secretion. Proc Natl Acad Sci U S A 87:4776–4780
     [Google Scholar]
  50. White D. G., Goldman J. D., Demple B., Levy S. B. 1997; Role of the acrAB locus in organic solvent tolerance mediated by expression of marA, soxS, or robA in Escherichia coli. J Bacteriol 179:6122–6126
     [Google Scholar]
  51. White D. G., Alekshun M. N., McDermott P. F. 2005; Frontiers in Antimicrobial Resistance: a Tribute to Stuart B. Levy Washington, DC: American Society for Microbiology;
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/mic.0.033415-0
Loading
Different effects of transcriptional regulators MarA, SoxS and Rob on susceptibility of Escherichia coli to cationic antimicrobial peptides (CAMPs): Rob-dependent CAMP induction of the marRAB operon
Microbiology 156, 570 (2010); https://doi.org/10.1099/mic.0.033415-0
/content/journal/micro/10.1099/mic.0.033415-0
/content/journal/micro/10.1099/mic.0.033415-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error